Ipsc-derived rejuvenated ctls
1 paper studies it
Across all fields, 1 paper: none in people yet, 1 review
Latest
[Rinsho Ketsueki] The Japanese Journal of Clinical Hematology
iPSC-derived next-generation T cell therapy for refractory malignancies
ReviewMalignancy